Data on migration of the non-invasive breast cancer cell line, MCF-7 treated with Bevacizumab using Real Time Cell Analyzer (RTCA)

Bevacizumab or Avastin® (Av), the recombinant antibody targeting VEGF, improves progression-free but not overall survival of metastatic breast cancer patients due to development of Av resistance. We showed that Av-therapy-induced inflammatory microenvironment contributes to the refractoriness to Av...

Descripción completa

Detalles Bibliográficos
Autores principales: EL-Hajjar, Layal, Shaito, Abdullah, Jalaleddine, Nour, Zibara, Kazem, Kazan, Jalal M., El-Saghir, Jamal, El-Sabban, Marwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Biochemistry, Genetics and Molecular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327074/
https://www.ncbi.nlm.nih.gov/pubmed/30671510
http://dx.doi.org/10.1016/j.dib.2018.12.059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327074/
https://www.ncbi.nlm.nih.gov/pubmed/30671510
http://dx.doi.org/10.1016/j.dib.2018.12.059

Ejemplares similares